0001127602-19-002688.txt : 20190125
0001127602-19-002688.hdr.sgml : 20190125
20190125081453
ACCESSION NUMBER: 0001127602-19-002688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190123
FILED AS OF DATE: 20190125
DATE AS OF CHANGE: 20190125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 19541204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-01-23
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
Chairman & CEO
Common Stock
2019-01-23
4
M
0
7054
52.65
A
7194
D
Common Stock
2019-01-23
4
S
0
1400
111.3614
D
5794
D
Common Stock
2019-01-23
4
S
0
2555
112.6279
D
3239
D
Common Stock
2019-01-23
4
S
0
2100
113.667
D
1139
D
Common Stock
2019-01-23
4
S
0
999
114.4529
D
140
D
Common Stock
2019-01-24
4
M
0
7054
52.65
A
7194
D
Common Stock
2019-01-24
4
S
0
5294
113.6677
D
1900
D
Common Stock
2019-01-24
4
S
0
1660
114.7457
D
240
D
Common Stock
2019-01-24
4
S
0
100
115.45
D
140
D
Common Stock
166
I
By Spouse
Common Stock
683489
I
By Trusts
Stock Options
52.65
2019-01-23
4
M
0
7054
0
D
2009-12-31
2019-12-31
Common Stock
7054
56434
D
Stock Options
52.65
2019-01-24
4
M
0
7054
0
D
2009-12-31
2019-12-31
Common Stock
7054
49380
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan (the "plan") entered into by the reporting person. The plan is designed to exercise and sell up to 148,138 stock options (which expire at the end of 2019) during the month of January 2019, in equal tranches of approximately 7,055 shares per day assuming certain conditions are met.
This transaction was executed in multiple trades at prices ranging from $110.81 to $111.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.08 to $112.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $113.125 to $114.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $114.15 to $114.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $113.32 to $114.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $114.34 to $115.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2019-01-24